CN101293004B - Medicament for treating chyluria - Google Patents

Medicament for treating chyluria Download PDF

Info

Publication number
CN101293004B
CN101293004B CN2008101237432A CN200810123743A CN101293004B CN 101293004 B CN101293004 B CN 101293004B CN 2008101237432 A CN2008101237432 A CN 2008101237432A CN 200810123743 A CN200810123743 A CN 200810123743A CN 101293004 B CN101293004 B CN 101293004B
Authority
CN
China
Prior art keywords
chyluria
drug
gram
medicine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101237432A
Other languages
Chinese (zh)
Other versions
CN101293004A (en
Inventor
李三猛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101237432A priority Critical patent/CN101293004B/en
Publication of CN101293004A publication Critical patent/CN101293004A/en
Application granted granted Critical
Publication of CN101293004B publication Critical patent/CN101293004B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a drug for treating chyluria, which is prepared by Chinese herbal medicines. The drug is characterized in that the drug comprises the medicines with the following weight: 30 to 60g of curly bristlethistle herb, 20 to 75g of burdock root, 30 to 90g of feather cockscomb seed and 30 to 100g of water calptrop base and peel. The whole formula has refined compatibility and orderly sequence, which can hit the disease mechanism and fully reflect the treatment principles of clearing heat, promoting diuresis, cooling blood, removing blood stasis, strengthening spleen and taking water.

Description

A kind of medicine for the treatment of chyluria
Technical field
The present invention relates to a kind of medicine for the treatment of chyluria, the particularly medicine made from Chinese herbal medicine.
Background technology
Chyluria is a kind of commonly encountered diseases, along with living standard improves, factors such as environmental pollution and operating pressure are big, this disease has and increases trend year by year, and chyluria is a kind of pertinacious disease, and the prolonged illness patient body is along with nutrition leak, health Zhejiang becomes loss, light influence life, heavy loses one's life, and brings white elephant to family social.Doctor trained in Western medicine is used and is given birth to the Drug therapys such as kobold sheet and penicillin of going out at present, curative effect is low, easily recurrence, it is little that Chinese medicine and Western medicine are compared apparent side effect, curative effect is lasting, and therapeutic effect is good, separates as present use inferior that to distinguish drink be exactly a kind of relatively good medicament, its composition by the river inferiorly separate, Cortex Phellodendri, Rhizoma Acori Graminei, Poria, Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, Lian Zixin, Semen Plantaginis, exist easy recurrence, shortcoming that curative effect is low in actual the use.
Purpose of the present invention, the shortcoming that exists in prior art and provide that a kind of to have the efficacy of a drug powerful can be effected a radical cure the medicine of chyluria exactly.
For achieving the above object, the present invention adopts following technical scheme:
A kind of medicine for the treatment of chyluria is characterized in that it is made up of the medicine of following weight: Herba Cardui Crispi 30-60 gram, Radix Arctii 20-75 gram, Flos Celosiae 30-90 gram, Pedicellus et Pericarpium Trapae 30-100 gram.
Press component weight and realize preferred plan of the present invention:
Herba Cardui Crispi 40 grams, Radix Arctii 45 grams, green grass or young crops are spent 60 grams, Pedicellus et Pericarpium Trapae 60 grams mutually.
Preparation method of the present invention is:
With Herba Cardui Crispi, Radix Arctii, the Flos Celosiae, Pedicellus et Pericarpium Trapae oven dry, pulverizing, cross 100 mesh sieves, the mixing sterilization incapsulates each by 0.35 gram dress, collects standby getting final product.
The effect achievement: the present invention treats the Chinese medicine of chyluria and each the Chinese medicine component in the preparation method: Herba Cardui Crispi, Radix Arctii, the Flos Celosiae three medicines are combined with the function of clearing away heat and expelling wind, inducing diuresis and reducing edema, cool the blood dissipate blood stasis.Pedicellus et Pericarpium Trapae has the function of replenishing QI to invigorate the spleen.Therefore, the present invention has the function of clearing away heat and expelling wind, dampness removing, detumescence, cool the blood dissipate blood stasis, replenishing QI to invigorate the spleen.
The present invention compares with traditional treatment chyluria medicine and has the following advantages:
The present invention is a pure Chinese medicinal preparation, is free from side effects, and short treating period removes merging filariid chyluria, and general equal the healing do not recurred.
Indication of the present invention: chyluria.
Instructions of taking: oral, every day three times, each 10, eliminating cold for resuscitation water send down, reduces by half more than 70 years old below 14 years old.
For showing medicine of the present invention, through 33 routine patient's clinical treatment observations: male's 15 examples, women's 17 examples to the chyluria therapeutic effect.
One, diagnostic criteria: the patient has obstinate, and through how tame hospital confirmed cases.
Two, observational technique: the clinical symptoms performance before and after the contrast therapy, and follow up a case by regular visits to more than 1 year.
Three, medication: every day three times, each 10.Seven days is a course of treatment, finishes the course of treatment, checks, and self changes before and after the contrast, stops other medicine during the medication.
Four, judge criterion of therapeutical effect:
1, cures: clinical symptom disappearance and not recurring in a year.
2, produce effects: clinical symptoms partly disappears.
3, invalid: clinical symptoms does not have obviously progressive.
Five, observe conclusion: cure 28 examples, account for 84.85%, produce effects 4 examples account for 12.12%, and invalid 1 example accounts for 3.03%, and total effective rate accounts for 96.97%.Have 3 examples to be associated with filariid in produce effects 4 examples, 1 example has bleeding agnogenio.
Specific implementation method
With Herba Cardui Crispi 40 gram, Radix Arctii 45 grams, the Flos Celosiae 60 grams, were pulverized 100 mesh sieves at Pedicellus et Pericarpium Trapae 60 gram oven dry, the mixing sterilization incapsulates, each is by 0.35 gram dress, oral one time 10, three times on the one, eliminating cold for resuscitation water send down.Reduce by half more than 70 years old below 14 years old and take.
Zhang Zongyang, the man 42 years old, was not healed through how tame hospitalize repeatedly, through 2 recoveries from illness courses of treatment in 24 years old ill 16 years.
Slander the luxuriant growth tinkling of pieces of jade, the woman, 42 years old, 28 years old was ill, showed effect repeatedly through how tame hospitalize, through using Drug therapy of the present invention, course of treatment recovery from illness.

Claims (1)

1. medicine for the treatment of chyluria, the raw material of wherein making active ingredient forms and weight proportion is: Herba Cardui Crispi 30-60 gram, Radix Arctii 20-75 gram, Flos Celosiae 30-90 gram, Pedicellus et Pericarpium Trapae 30-100 gram.
CN2008101237432A 2008-06-02 2008-06-02 Medicament for treating chyluria Expired - Fee Related CN101293004B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101237432A CN101293004B (en) 2008-06-02 2008-06-02 Medicament for treating chyluria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101237432A CN101293004B (en) 2008-06-02 2008-06-02 Medicament for treating chyluria

Publications (2)

Publication Number Publication Date
CN101293004A CN101293004A (en) 2008-10-29
CN101293004B true CN101293004B (en) 2011-09-14

Family

ID=40063712

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101237432A Expired - Fee Related CN101293004B (en) 2008-06-02 2008-06-02 Medicament for treating chyluria

Country Status (1)

Country Link
CN (1) CN101293004B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1687369A (en) * 2005-04-19 2005-10-26 石泽生 Longevity medicinal wine and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1687369A (en) * 2005-04-19 2005-10-26 石泽生 Longevity medicinal wine and preparation method thereof

Also Published As

Publication number Publication date
CN101293004A (en) 2008-10-29

Similar Documents

Publication Publication Date Title
CN101874874B (en) Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof
CN103301400B (en) A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis
CN103055260B (en) Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof
CN102038829A (en) Medicament for treating gastritis and ulcers of stomachs and duodenums
CN103211990A (en) Chinese medicinal composition for treating oral ulcer
CN102949685A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN102727848B (en) Pure traditional Chinese medicine composition used for treating poultry infectious bursal disease, and preparation method thereof
CN104288477A (en) Traditional Chinese medicine preparation curing infantile asthma
CN102727786A (en) Chinese traditional medicine for treating chronic gastritis
CN103446545B (en) Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof
CN103830609B (en) A kind of Chinese medicine preparation for the treatment of cough and expectoration
CN101293004B (en) Medicament for treating chyluria
CN103099879B (en) Traditional Chinese medicine (TCM) preparation for treating fifth-watch diarrhea
CN103127473A (en) Pain-relieving paste
CN101979061A (en) Antiemetic medicine
CN101972456B (en) Medicament for treating liver-stomach disharmony type chest and hypochondrium swelling pain
CN104800772A (en) Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition
CN103933269A (en) Traditional Chinese medicine for treating metrorrhagia disease
CN103263645B (en) Gastritis and gastric ulcer treatment drug
CN102813824A (en) Medicament for treating gastropathy
CN106038964A (en) Traditional Chinese medicine composition for treating acute lumbar sprain
CN105362596A (en) Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof
CN104398726A (en) Traditional Chinese medicine for treating diarrhea and preparing method thereof
CN101041051A (en) Chinese traditional medicine compound took orally for treating Xuhan type bacterial dysentery
CN103845480A (en) Traditional Chinese medicine for treating secondary peritonitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110914

Termination date: 20160602